Bausch Health Companies Inc. (BHC) — Business segments and KPIs
Revenue by business segment and geography for Bausch Health Companies Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 10.16B | 49.5% |
| Pharmaceutical Products | 4.75B | 23.1% |
| Device Products | 2.44B | 11.9% |
| Over the Counter Products | 2.01B | 9.8% |
| Branded and Other Generic Products | 962M | 4.7% |
| Other Revenues | 110M | 0.5% |
| Product and Service, Other | 110M | 0.5% |
| Revenue by region | ||
| United States and Puerto Rico | 6.14B | 61.8% |
| Other Countries | 1.15B | 11.6% |
| CHINA | 493M | 5.0% |
| CANADA | 417M | 4.2% |
| POLAND | 382M | 3.8% |
| MEXICO | 278M | 2.8% |
| FRANCE | 249M | 2.5% |
| KOREA, REPUBLIC OF | 234M | 2.4% |
| JAPAN | 192M | 1.9% |
| GERMANY | 176M | 1.8% |
| SPAIN | 109M | 1.1% |
| ITALY | 106M | 1.1% |